Thursday, November 19, 2026

Oman News

Oman’s Health Ministry warns of rare vision loss risk linked to popular diabetes and weight-loss drugs

Oman's Ministry of Health has warned of a potential link between certain GLP-1 medications and tirzepatide and a rare eye condition that could cause sudden vision loss.

TAS News Service

info@thearabianstories.com

Thursday, November 19, 2026

MUSCAT : The warning, issued by the Ministry’s Drug Safety Centre, refers to 2025/2026 safety data and an update issued by the US Food and Drug Administration (FDA) on November 9, 2026.

According to the alert, these medications may be associated with an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare disorder affecting the optic nerve that can lead to sudden vision loss.

The Ministry has urged people taking the medications to seek immediate medical attention if they experience sudden vision loss, blurred vision, blind spots or changes in colour vision, even if the symptoms are not accompanied by pain.

The medicines covered by the warning include semaglutide (Ozempic, Rybelsus and Wegovy), liraglutide (Saxenda and Victoza), dulaglutide (Trulicity) and tirzepatide (Mounjaro and Zepbound).

These medications are used to treat type 2 diabetes, while certain formulations are also approved for weight management in people with obesity or overweight accompanied by related health conditions. Their use should follow the approved indications for each product and take place under medical supervision.

The Ministry has advised patients not to stop taking their medication or change their prescribed dosage without first consulting their doctor. It has also emphasised the importance of following medical instructions and reporting any suspected adverse drug reactions.

Patients and healthcare professionals can report suspected side effects through the Ministry of Health website by accessing the Drug Safety Centre and its Pharmacovigilance Department.

The Ministry reiterated the importance of safe medication use, early recognition of potential side effects and prompt medical assessment, particularly when sudden changes in vision occur.

For all the latest news from Oman and GCC, follow us on Twitter, Instagram and LinkedIn, like us on Facebook and subscribe to our YouTube page, which is updated daily.

Close